Видео ютуба по тегу Anti-Cd19

Anti-CD19 Monoclonal Antibody Therapy in DLBCL
Anti-CD19 Monoclonal Antibody Therapy in DLBCL
CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell ALL
CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell ALL
Bispecific CAR T-cell therapy: combining anti-CD19 and CD22 CAR T-cells
Bispecific CAR T-cell therapy: combining anti-CD19 and CD22 CAR T-cells
Dr. Shah on Differences Between Anti–CD19 CAR T-Cell Therapies
Dr. Shah on Differences Between Anti–CD19 CAR T-Cell Therapies
Out of specification anti-CD19 CAR T-cell products in aggressive B-cell lymphomas
Out of specification anti-CD19 CAR T-cell products in aggressive B-cell lymphomas
Anti-CD19 CAR-T for Richter’s transformation: an international multicenter retrospective study
Anti-CD19 CAR-T for Richter’s transformation: an international multicenter retrospective study
Transplant Ineligibility: Anti-CD19 Combination Therapy
Transplant Ineligibility: Anti-CD19 Combination Therapy
Fully human anti-CD19 and CD22 bispecific tandem CAR-T
Fully human anti-CD19 and CD22 bispecific tandem CAR-T
Mechanism of Action: T Cell Engagers Targeting CD19
Mechanism of Action: T Cell Engagers Targeting CD19
Exploring novel humanized anti-CD19 CAR-T cells as a strategy to minimize CRS and other toxicities
Exploring novel humanized anti-CD19 CAR-T cells as a strategy to minimize CRS and other toxicities
Safety profile of anti-CD19 CAR T-cell therapy axicabtagene ciloleucel
Safety profile of anti-CD19 CAR T-cell therapy axicabtagene ciloleucel
Diminished chronic GvHD symptoms following anti-CD19 CAR T-cell therapy: a case study
Diminished chronic GvHD symptoms following anti-CD19 CAR T-cell therapy: a case study
Anti-CD19 monoclonal antibodies for the treatment of DLBCL
Anti-CD19 monoclonal antibodies for the treatment of DLBCL
CD19 CAR T-cells for adults
CD19 CAR T-cells for adults
Anti-CD19 CAR T-cells for adults
Anti-CD19 CAR T-cells for adults
A targeted treatment with anti-CD19 CAR T-cells results in different responses
A targeted treatment with anti-CD19 CAR T-cells results in different responses
Infusion of allogeneic anti-CD19 CAR T-cells is a promising approach after alloHSCT
Infusion of allogeneic anti-CD19 CAR T-cells is a promising approach after alloHSCT
Dr. Brudno on Allogeneic T Cells Expressing an Anti-CD19 CAR in B-Cell Malignancies
Dr. Brudno on Allogeneic T Cells Expressing an Anti-CD19 CAR in B-Cell Malignancies
Bispecific anti-CD20, anti-CD19 CAR-Ts for R/R NHL
Bispecific anti-CD20, anti-CD19 CAR-Ts for R/R NHL
ENABLE: third-generation anti-CD19 CAR for R/R NHL
ENABLE: third-generation anti-CD19 CAR for R/R NHL